Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Abstract Background COVID-19 is a highly infectious respiratory disease. No therapeutics have yet been proven effective for treating severe COVID-19. Objectives To determine whether human umbilical cord mesenchymal stem cell infusion may be effective and safe for the treatment of severe COVID-19. Me...

Full description

Bibliographic Details
Main Authors: Lei Shu, Changming Niu, Ruyou Li, Tingrong Huang, Yan Wang, Mao Huang, Ningfei Ji, You Zheng, Xiaolin Chen, Lei Shi, Mingjing Wu, Kaili Deng, Jing Wei, Xueli Wang, Yang Cao, Jiaxin Yan, Ganzhu Feng
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Stem Cell Research & Therapy
Subjects:
Coronavirus disease-19 (COVID-19)
Clinical characteristics
Coronavirus pneumonia
Human umbilical cord mesenchymal stem cells
Online Access:http://link.springer.com/article/10.1186/s13287-020-01875-5

Internet

http://link.springer.com/article/10.1186/s13287-020-01875-5

Similar Items